Identifying fertilization-ready metaphase II stage oocytes beyond the microscope: a proposed molecular path forward

Bei Sun B.S. , John Yeh M.D.
{"title":"Identifying fertilization-ready metaphase II stage oocytes beyond the microscope: a proposed molecular path forward","authors":"Bei Sun B.S. ,&nbsp;John Yeh M.D.","doi":"10.1016/j.xfnr.2021.09.001","DOIUrl":null,"url":null,"abstract":"<div><p>One key variable in the success of in vitro fertilization (IVF) cycles is the maturation of oocytes for fertilization. Current practices of both conventional IVF and intracytoplasmic sperm injection do not evaluate the maturity of eggs immediately at the time of oocyte retrieval. In conventional IVF, all retrieved eggs are inseminated with sperm without further evaluation of their maturity. With conventional IVF, immature oocytes are not identified and are inseminated with resulting poor outcomes. In intracytoplasmic sperm injection, retrieved eggs are denuded of cumulus cells (CCs) for evaluation of maturity before insemination. Immature oocytes are identified after denudation and may not reach their full maturation potential because of the loss of surrounding CCs. Both approaches can benefit from an early noninvasive evaluation of oocyte maturity. Cumulus cells are physically and biochemically connected to oocytes and could serve as a window to look into oocyte maturity. This study reviews current literature on processes essential in oocyte maturation involving CCs as well as messenger RNA (mRNA), microRNA (miRNA), and protein biomarkers of metaphase II (MII) stage oocytes identified in CCs. We use this information as a starting point to propose a path forward in the molecular analysis of CCs as a tool of MII oocyte selection. With future studies proposed in this review, we envision a clinically useful approach of selected mRNA, miRNA, and protein marker analysis and eventually a transition to mRNA–miRNA–protein expression correlation analysis and pathway analysis of CC markers to identify MII oocytes at the time of retrieval and enable metaphase I and germinal vesicle oocytes to be further matured in vitro with intact supporting CCs.</p></div>","PeriodicalId":73011,"journal":{"name":"F&S reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.xfnr.2021.09.001","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F&S reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666571921000189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

One key variable in the success of in vitro fertilization (IVF) cycles is the maturation of oocytes for fertilization. Current practices of both conventional IVF and intracytoplasmic sperm injection do not evaluate the maturity of eggs immediately at the time of oocyte retrieval. In conventional IVF, all retrieved eggs are inseminated with sperm without further evaluation of their maturity. With conventional IVF, immature oocytes are not identified and are inseminated with resulting poor outcomes. In intracytoplasmic sperm injection, retrieved eggs are denuded of cumulus cells (CCs) for evaluation of maturity before insemination. Immature oocytes are identified after denudation and may not reach their full maturation potential because of the loss of surrounding CCs. Both approaches can benefit from an early noninvasive evaluation of oocyte maturity. Cumulus cells are physically and biochemically connected to oocytes and could serve as a window to look into oocyte maturity. This study reviews current literature on processes essential in oocyte maturation involving CCs as well as messenger RNA (mRNA), microRNA (miRNA), and protein biomarkers of metaphase II (MII) stage oocytes identified in CCs. We use this information as a starting point to propose a path forward in the molecular analysis of CCs as a tool of MII oocyte selection. With future studies proposed in this review, we envision a clinically useful approach of selected mRNA, miRNA, and protein marker analysis and eventually a transition to mRNA–miRNA–protein expression correlation analysis and pathway analysis of CC markers to identify MII oocytes at the time of retrieval and enable metaphase I and germinal vesicle oocytes to be further matured in vitro with intact supporting CCs.

鉴定受精准备中期II期卵母细胞超越显微镜:提出的分子路径前进
体外受精(IVF)周期成功的一个关键变量是卵母细胞的成熟。目前的常规试管受精和卵浆内单精子注射都不能在取卵时立即评估卵子的成熟度。在传统的体外受精中,所有取出的卵子都与精子受精,而不进一步评估它们的成熟度。在传统的体外受精中,未成熟的卵母细胞不能被识别出来,并被人工授精,结果很差。在卵胞浆内单精子注射中,取出的卵子被剥去积云细胞(CCs),以便在授精前评估成熟度。未成熟卵母细胞是在脱落后被识别出来的,由于周围细胞的丢失,它们可能无法达到完全成熟的潜力。两种方法都可以受益于卵母细胞成熟度的早期无创评估。卵丘细胞与卵母细胞在物理和生物化学上都有联系,可以作为观察卵母细胞成熟度的窗口。本研究综述了目前有关卵母细胞成熟过程的文献,这些过程涉及cc以及在cc中鉴定的中期II (MII)期卵母细胞的信使RNA (mRNA)、microRNA (miRNA)和蛋白质生物标志物。我们利用这些信息作为起点,提出了一个途径,在分子分析CCs作为MII卵母细胞选择的工具。在本综述中提出的未来研究中,我们设想了一种临床有用的方法,即选择mRNA, miRNA和蛋白质标记分析,并最终过渡到mRNA - miRNA -蛋白质表达相关性分析和CC标记的途径分析,以在检索时识别MII卵母细胞,并使中期I和生发囊泡卵母细胞在体外进一步成熟,并具有完整的支持CC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
F&S reviews
F&S reviews Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Urology
CiteScore
3.70
自引率
0.00%
发文量
0
审稿时长
61 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信